About: Impact of covid-19 lockdown on glycemic control in patients with type 1 diabetes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of covid-19 lockdown on glycemic control in patients with type 1 diabetes Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Impact of covid-19 lockdown on glycemic control in patients with type 1 diabetes
Creator	Bellido, Dra Bellido, Virginia Cortazar, Alicia Fernández, Elsa Orcid, Phd
Source	Elsevier; Medline; PMC
abstract	INTRODUCTION: The COVID-19 pandemic has forced governments to take exceptional measures to minimize its spread, imposing lockdown policies. The aim of this study was to evaluate the impact of lockdown on type 1 diabetes (T1D) glycemic control. MATERIAL AND METHODS: People with T1D using flash glucose monitoring were included. Data from the 14 days before lockdown were compared with data from the last 14 days after 8 weeks of lockdown. RESULTS: A total of 307 patients were included (age 45.8±12.6 years, 50.2% male, diabetes duration 21.1±12.3 years). Only one patient had COVID-19 infection. Mean glucose decreased from 166.89±29.4 mg/dL to 158.0±29.0 and estimated HbA1c declined from 7.4±1.0 to 7.1±1.0% (54±10.9 vs 57±10.9 mmol/mol; p<0.001). Time in range increased from 57.8±15.8 to 62.46±16.1%. Time in hyperglycemia >180 mg/dL and >250 mg/dL decreased from 37.3±1.9% to 32.0±17.1% and from 13.0±11.3 to 10.3±10.6%, respectively; (p<0.001). Time in hypoglycemia <70mg/dL increased from 4.9±4.0% to 5.5±4.4% (p<0.001). No differences in time <54 mg/dl, coefficient of variation (CV%) or number of scans per day were found. CONCLUSION: Despite the limitations of lockdown, glycemic control improved in patients with T1D. These results suggest that having more time for self-management may help improve glycemic control in the short term.
has issue date	2020-07-22(xsd:dateTime)
bibo:doi	10.1016/j.diabres.2020.108348
bibo:pmid	32711000
has license	no-cc
sha1sum (hex)	70d1bfc6944cd92413a3a2e40b42f02c7a43119a
schema:url	https://doi.org/10.1016/j.diabres.2020.108348
resource representing a document's title	Impact of covid-19 lockdown on glycemic control in patients with type 1 diabetes
has PubMed Central identifier	PMC7375311
has PubMed identifier	32711000
schema:publication	Diabetes Res Clin Pract
resource representing a document's body	covid:70d1bfc6944cd92413a3a2e40b42f02c7a43119a#body_text
is schema:about of	named entity 'SARS-CoV-2' named entity 'INJECTIONS' named entity 'ABBREVIATIONS' named entity 'T1D' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'type 1' named entity 'TYPE' named entity 'glycemic control' named entity 'type 2 diabetes' named entity 'type 1 diabetes' named entity 'insulin injections' named entity 'coefficient of variation' named entity 'covid-19' named entity '1.6' named entity 'infection' named entity '9.9' named entity 'digital medicine' named entity 'daily activities' named entity 'T1D' named entity 'insulin injections' named entity 'glycemic control' named entity 'T1D' named entity 'diabetes' named entity 'FGM' named entity 'comorbidities' named entity 'follow-up' named entity 'hypoglycemia' named entity 'T1D' named entity 'COVID-19 infection' named entity 'glycemic control' named entity 'CGM' named entity 'self-management' named entity 'Nutrition' named entity 'mg/dl' named entity 'COVID' named entity 'hypoglycemia' named entity 'selection bias' named entity 'FGM' named entity 'hyperglycemia' named entity 'CGM' named entity 'hypoglycemia' named entity '4.7' named entity 'Coronavirus disease 2019' named entity 'hypoglycemia' named entity 'telemedicine' named entity 'glycemic control' named entity 'TIR' named entity 'severe acute respiratory syndrome' named entity 'glucose levels' named entity 'hypoglycemia' named entity 'HbA1c' named entity 'T1D' named entity 'COVID' named entity 'FGM' named entity 'CGM' named entity 'comorbidities' named entity 'prognosis' named entity 'mg/dl' named entity 'China' named entity 'T1D' named entity 'T1D' named entity 'COVID-19' named entity 'hyperglycemia' named entity 'comorbidities' named entity 'COVID-19 pandemic' named entity 'T2D' named entity 'sensor' named entity 'anxiety' named entity 'T1D' named entity 'statistically significant' named entity 'hyperglycemia' named entity 'mg/dl' named entity 'insulin pump' named entity 'mmol' named entity 'glycemic control' named entity '8.3' named entity 'general hospital'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software